Tata India Pharma & Healthcare Fund vs DSP Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1296 Cr | ₹3074 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 28 Dec 2015 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 18% |
| Expense Ratio | 2.14 | 1.9 |
| Manager | Meeta Shetty | Jay Kothari |
| ISIN Code | INF277K016A9 | INF740KA1LD8 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | 1% | 2.76% |
| 6 Month | 5.24% | 8.32% |
| 1 Year | 4.99% | -1.23% |
| 3 Year | 21.94% | 21.36% |
| 5 Year | 17.77% | 17.55% |
SIP Return Analysis
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | 0.65% | 1.06% |
| 1 Year | 7.63% | 5.84% |
| 3 Year | 19.55% | 18.57% |
| 5 Year | 17.8% | 17.62% |
Rolling Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 8.89% | 24.42% |
| 3 Year | 18.72% | 21.37% |
| 5 Year | 15.51% | 25.82% |
Risk Management
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 16.04% | 14.63% |
| Sharp | 0.90% | 0.98% |
| Beta | 0.97% | 0.84% |
| Alpha | -0.83% | 1.19% |
Fund Managers
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Meeta Shetty | Jay Kothari |
| Total AUM | ₹17847 Cr | ₹0 Cr |
| Funds Managed | 5 | 20 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 4.14 | 15.67 |
| Large Cap | 25.14 | 16.72 |
| Mid Cap | 37.44 | 14.23 |
| Small Cap | 33.28 | 53.38 |
Sector Allocation
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.72 | 2.73 |
| Healthcare | 94.07 | 95.78 |
| Basic Materials | 2.64 | - |
| Financial Services | 1.58 | 1.48 |
Top Comparisons
INVESCO INDIA FOCUSED FUND - Growth
3Y Returns22.2%
Motilal Oswal Focused 25 Fund (MOF25)- Regular Plan Growth Option
3Y Returns9.25%
Nippon India Consumption Fund-Growth Plan-Growth Option
3Y Returns15.5%
Tata India Consumer Fund-Regular Plan-Growth
3Y Returns18.8%
PGIM India Aggressive Hybrid Equity Fund - Growth Option
3Y Returns12.55%
UTI Aggressive Hybrid Fund- Regular Plan - Growth
3Y Returns16.26%
SBI Short Horizon Debt Fund-Short Term Fund - Retail - Growth
3Y Returns7.55%
DSP Short Term Fund - Regular Plan - Growth
3Y Returns7.31%